Skip to content

Cardiac CT Evaluation of EAT in AF vs. Non-AF Subjects

Cardiac Computed Tomography Evaluation of Epicardial Adipose Tissue Differences Between Patients With Atrial Fibrillation and Non-Atrial Fibrillation Individuals

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07320261
Acronym
CCT-EAT-AF-NA
Enrollment
600
Registered
2026-01-06
Start date
2026-01-01
Completion date
2026-08-31
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF), CT

Brief summary

The goal of this cross-sectional study is to explore the relationship between atrial structural characteristics (such as epicardial adipose tissue infiltration and atrial size) and atrial fibrillation (AF), as well as the differences in these characteristics among different AF subtypes. It will also clarify the independent association between pericardial fat distribution and AF (and its subtypes) after excluding confounding factors. The main questions it aims to answer are: * What are the differences in epicardial adipose tissue volume and atrial size among patients with sinus rhythm, paroxysmal AF, and persistent AF? * Is pericardial fat distribution independently associated with AF and its subtypes after adjusting for confounding factors such as age, hypertension, and left atrial enlargement? Researchers will enroll patients who undergo coronary CTA or left atrial CTA at The Second Affiliated Hospital of Zhejiang University School of Medicine, and match and divide them into three groups (sinus rhythm group, paroxysmal AF group, and persistent AF group) based on BMI and other factors. They will compare the differences in pericardial fat distribution and baseline characteristics among the three groups and analyze the independent association between pericardial fat and AF. Participants will: * Provide relevant clinical baseline data and CTA examination results * Complete the collection of demographic information, medical history, and laboratory test data The study duration is 6 months, starting from the date of ethical approval, with an expected end date of June 2026. A total of 600-900 participants (200-300 per group) will be enrolled to ensure the reliability and clinical applicability of the research conclusions.

Interventions

None listed

Sponsors

University of Auckland, New Zealand
CollaboratorOTHER
xiaoya wang
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients who undergo coronary CTA or left atrial CTA examination at The Second Affiliated Hospital of Zhejiang University School of Medicine; * Aged 18 years or older * Cardiac rhythm status is confirmed as sinus rhythm, paroxysmal atrial fibrillation, or persistent atrial fibrillation; * Willing to provide clinical baseline data and allow access to CTA examination results; * Able to understand and cooperate with the data collection process of the study.

Exclusion criteria

* Patients with incomplete clinical baseline data or unreadable CTA images; * Aged less than 18 years * Patients who refuse to participate in the study or cannot cooperate with data collection; * Other situations judged by the researchers to be unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
The difference in epicardial adipose tissue distribution among the three cohortsAt the time of enrollment

Contacts

Primary ContactXiaoya Wang, Doctor
wxyonce@zju.edu.cn86-0571-87784704

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026